Long-term use and tolerability of irbesartan for control of hypertension
In this review, we discuss the pharmacological and clinical properties of irbesartan, a noncompetitive angiotensin II receptor type 1 antagonist, successfully used for more than a decade in the treatment of essential hypertension. Irbesartan exerts its antihypertensive effect through an inhibitory e...
Main Authors: | Forni, Valentina, Wuerzner, Grégoire, Pruijm, Menno, Burnier, Michel |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172075/ |
Similar Items
-
Clinical Benefits of an Adherence Monitoring Program in the Management of Secondary Hyperparathyroidism with Cinacalcet: Results of a Prospective Randomized Controlled Study
by: Forni Ogna, Valentina, et al.
Published: (2013) -
Determinants of persistence in hypertensive patients treated with irbesartan: results of a postmarketing survey
by: Burnier, Michel, et al.
Published: (2005) -
Critical review of cancer risk associated with angiotensin receptor blocker therapy
by: Wuerzner, Grégoire, et al.
Published: (2011) -
Salt, blood pressure and cardiovascular risk: what is the most adequate preventive strategy? A Swiss perspective
by: Burnier, Michel, et al.
Published: (2015) -
Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan
by: Gialama, Fotini, et al.
Published: (2013)